IL-16 signaling specifically induces STAT6 activation through CD4

Cytokine

Volumn 38, Issue 3, 2007, Pages 145-150

  Liu, Changbao ^a   Mills, Juliane ^a   Dixon, Ken ^a   Vennarini, Joseph ^a   Cunningham, Mark ^a   Del Vecchio, Alfred ^a   Das, Anuk ^a   Glass, William ^a  

^a CENTOCOR INC   (United States)

Author keywords

CD4; Interleukin 16; STAT6

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 16; STAT6 PROTEIN;

ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LEUKOCYTE CULTURE; NEUTROPHIL CHEMOTAXIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; UPREGULATION;

ANTIGENS, CD4; BASE SEQUENCE; CELL LINE; DNA PRIMERS; HUMANS; INTERLEUKIN-16; LEUKOCYTES, MONONUCLEAR; PHOSPHORYLATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR;

EID: 34547830377     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.05.016     Document Type: Article

References (33)

1. Cruikshank W., and Center D.M. Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). J Immunol 128 6 (1982) 2569-2574
2. Center D.M., and Cruikshank W. Modulation of lymphocyte migration by human lymphokines I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J Immunol 128 6 (1982) 2563-2568
3. Bacon K., Baggiolini M., Broxmeyer H., Horuk R., Lindley I., Mantovani A., Maysushima K., Murphy P., Nomiyama H., Oppenheim J., Rot A., Schall T., Tsang M., Thorpe R., Van Damme J., Wadhwa M., Yoshie O., Zlotnik A., and Zoon K. Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22 10 (2002) 1067-1068
4. Muhlhahn P., Zweckstetter M., Georgescu J., Ciosto C., Renner C., Lanzendorfer M., Lang K., Ambrosius D., Baier M., Kurth R., and Holak T.A. Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site. Nat Struct Biol 5 8 (1998) 682-686
5. Laberge S., Cruikshank W.W., Beer D.J., and Center D.M. Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. J Immunol 156 1 (1996) 310-315
6. Laberge S., Ghaffar O., Boguniewicz M., Center D.M., Leung D.Y., and Hamid Q. Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis. J Allergy Clin Immunol 102 4 Pt 1 (1998) 645-650
7. Lim K.G., Wan H.C., Bozza P.T., Resnick M.B., Wong D.T., Cruikshank W.W., Kornfeld H., Center D.M., and Weller P.F. Human eosinophils elaborate the lymphocyte chemoattractants IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol 156 7 (1996) 2566-2570
8. Rumsaeng V., Cruikshank W.W., Foster B., Prussin C., Kirshenbaum A.S., Davis T.A., Kornfeld H., Center D.M., and Metcalfe D.D. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol 159 6 (1997) 2904-2910
9. Wu D.M., Zhang Y., Parada N.A., Kornfeld H., Nicoll J., Center D.M., and Cruikshank W.W. Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent. J Immunol 162 3 (1999) 1287-1293
10. Bellini A., Yoshimura H., Vittori E., Marini M., and Mattoli S. Bronchial epithelial cells of patients with asthma release chemoattractant factors for T lymphocytes. J Allergy Clin Immunol 92 3 (1993) 412-424
11. Hermann E., Darcissac E., Idziorek T., Capron A., and Bahr G.M. Recombinant interleukin-16 selectively modulates surface receptor expression and cytokine release in macrophages and dendritic cells. Immunology 97 2 (1999) 241-248
12. Center D.M., Cruikshank W.W., and Zhang Y. Nuclear pro-IL-16 regulation of T cell proliferation: p27(KIP1)-dependent G0/G1 arrest mediated by inhibition of Skp2 transcription. J Immunol 172 3 (2004) 1654-1660
13. Wilson K.C., Center D.M., and Cruikshank W.W. The effect of interleukin-16 and its precursor on T lymphocyte activation and growth. Growth Factors 22 2 (2004) 97-104
14. Theodore A.C., Center D.M., Nicoll J., Fine G., Kornfeld H., and Cruikshank W.W. CD4 ligand IL-16 inhibits the mixed lymphocyte reaction. J Immunol 157 5 (1996) 1958-1964
15. Cruikshank W.W., Lim K., Theodore A.C., Cook J., Fine G., Weller P.F., and Center D.M. IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J Immunol 157 12 (1996) 5240-5248
16. Van Drenth C., Jenkins A., Ledwich L., Ryan T.C., Mashikian M.V., Brazer W., Center D.M., and Cruikshank W.W. Desensitization of CXC chemokine receptor 4, mediated by IL-16/CD4, is independent of p56lck enzymatic activity. J Immunol 165 11 (2000) 6356-6363
17. Parada N.A., Cruikshank W.W., Danis H.L., Ryan T.C., and Center D.M. IL-16 and other CD4 ligand-induced migration is dependent upon protein kinase C. Cell Immunol 168 1 (1996) 100-106
18. Zhang X.M., and Xu Y.H. The associated regulators and signal pathway in rIL-16/CD4 mediated growth regulation in Jurkat cells. Cell Res 12 5-6 (2002) 363-372
19. Krautwald S. IL-16 activates the SAPK signaling pathway in CD4+ macrophages. J Immunol 160 12 (1998) 5874-5879
20. Graziani-Bowering G., Filion L.G., Thibault P., and Kozlowski M. CD4 is active as a signaling molecule on the human monocytic cell line Thp-1. Exp Cell Res 279 1 (2002) 141-152
21. Qi J.C., Wang J., Mandadi S., Tanaka K., Roufogalis B.D., Madigan M.C., Lai K., Yan F., Chong B.H., Stevens R.L., and Krilis S.A. Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor. Blood 107 1 (2006) 135-142
22. Rand T.H., Cruikshank W.W., Center D.M., and Weller P.F. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med 173 6 (1991) 1521-1528
23. Hebenstreit D., Wirnsberger G., Horejs-Hoeck J., and Duschl A. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 17 3 (2006) 173-188
24. Kubo M., Ransom J., Webb D., Hashimoto Y., Tada T., and Nakayama T. T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6. Embo J 16 13 (1997) 4007-4020
25. Curiel R.E., Lahesmaa R., Subleski J., Cippitelli M., Kirken R.A., Young H.A., and Ghosh P. Identification of a Stat-6-responsive element in the promoter of the human interleukin-4 gene. Eur J Immunol 27 8 (1997) 1982-1987
26. Bandeira-Melo C., Sugiyama K., Woods L.J., Phoofolo M., Center D.M., Cruikshank W.W., and Weller P.F. IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling. J Immunol 168 9 (2002) 4756-4763
27. Mashikian M.V., Ryan T.C., Seman A., Brazer W., Center D.M., and Cruikshank W.W. Reciprocal desensitization of CCR5 and CD4 is mediated by IL-16 and macrophage-inflammatory protein-1 beta, respectively. J Immunol 163 6 (1999) 3123-3130
28. Parada N.A., Center D.M., Kornfeld H., Rodriguez W.L., Cook J., Vallen M., and Cruikshank W.W. Synergistic activation of CD4+ T cells by IL-16 and IL-2. J Immunol 160 5 (1998) 2115-2120
29. Cruikshank W.W., Center D.M., Nisar N., Wu M., Natke B., Theodore A.C., and Kornfeld H. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci USA 91 11 (1994) 5109-5113
30. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268 20 (1993) 14553-14556
31. Rousseau S., Dolado I., Beardmore V., Shpiro N., Marquez R., Nebreda A.R., Arthur J.S., Case L.M., Tessier-Lavigne M., Gaestel M., Cuenda A., and Cohen P. CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway. Cell Signal (2006)
32. Keren A., Tamir Y., and Bengal E. The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol Cell Endocrinol 252 1-2 (2006) 224-230
33. Shimoda K., van Deursen J., Sangster M.Y., Sarawar S.R., Carson R.T., Tripp R.A., Chu C., Quelle F.W., Nosaka T., Vignali D.A., Doherty P.C., Grosveld G., Paul W.E., and Ihle J.N. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380 6575 (1996) 630-633